These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35174108)

  • 21. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
    Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
    PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
    Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa.
    Bertelsen A; Elborn SJ; Schock BC
    PLoS One; 2020; 15(10):e0235803. PubMed ID: 33031374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A commensal streptococcus hijacks a Pseudomonas aeruginosa exopolysaccharide to promote biofilm formation.
    Scoffield JA; Duan D; Zhu F; Wu H
    PLoS Pathog; 2017 Apr; 13(4):e1006300. PubMed ID: 28448633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dpr-mediated H
    Rogers RR; Kesthely CA; Jean-Pierre F; El Hafi B; O'Toole GA
    J Bacteriol; 2024 Jul; 206(7):e0017624. PubMed ID: 38940597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.
    Twomey KB; O'Connell OJ; McCarthy Y; Dow JM; O'Toole GA; Plant BJ; Ryan RP
    ISME J; 2012 May; 6(5):939-50. PubMed ID: 22134647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.
    Young RL; Malcolm KC; Kret JE; Caceres SM; Poch KR; Nichols DP; Taylor-Cousar JL; Saavedra MT; Randell SH; Vasil ML; Burns JL; Moskowitz SM; Nick JA
    PLoS One; 2011; 6(9):e23637. PubMed ID: 21909403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease.
    Cobb LM; Mychaleckyj JC; Wozniak DJ; López-Boado YS
    J Immunol; 2004 Nov; 173(9):5659-70. PubMed ID: 15494517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung and Gut Microbiota Changes Associated with
    Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Pseudomonas aeruginosa and Streptococcus mitis mixed infection on TLR4-mediated immune response in acute pneumonia mouse model.
    Song C; Li H; Zhang Y; Yu J
    BMC Microbiol; 2017 Apr; 17(1):82. PubMed ID: 28376744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways.
    Gabrielaite M; Johansen HK; Molin S; Nielsen FC; Marvig RL
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.
    Yoo DG; Winn M; Pang L; Moskowitz SM; Malech HL; Leto TL; Rada B
    J Immunol; 2014 May; 192(10):4728-38. PubMed ID: 24740504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
    Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
    J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.